YannTong Chiang

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang et al. · Circulation · 2003 · 861 citations

Medicine, Cardiology, Pharmacology +12

Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients

Alan H. Gradman, Roland E. Schmieder, R. Lins et al. · Circulation · 2005 · 524 citations

Medicine, Pharmacology, Pharmacotherapy +17

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

George L. Bakris, Pantelis Sarafidis, Björn Dahlöf et al. · The Lancet · 2010 · 518 citations

Pharmacy, Nephrology, Pharmacotherapy +9

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

David R. Matthews, Päivi M. Paldánius, Pieter Proot et al. · The Lancet · 2019 · 355 citations

Medicine, Pharmacology, Pharmacotherapy +16

Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure

Roberto Latini, Serge Masson, Inder S. Anand et al. · Circulation · 2002 · 295 citations

Medicine, Cardiology, Pharmacology +15